DepressionNCT05047081
From Intention to Action:Scoring Your College Goals
A study testing Scoring Your College Goals Workshop in people with Depression and Anxiety, run by The Zucker Hillside Hospital at 1 site in United States.
Trial summary
The current study aims to prevent the developmental of mental health symptoms in first-year college students through providing a workshop aimed at preparing students for the academic, social, and personal challenges associated with typical college experiences. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Depression, Anxiety
- What is being tested?
- Scoring Your College Goals Workshop
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 126 participants
- Where
- 1 siteUnited States
- Study dates
- 27 Aug 2021to 30 Apr 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- First-year, first semester freshman enrolled in Psychology 100 courses at CUNY College of Staten Island.
Who cannot join
- Under 18 years old
- Violation of inclusion criteria
Trial locations and contacts
1 site in 1 country.
United States1 site
CUNY College of State Island
Staten Island, New York, 10314
About this study
Official title: Scoring Your College Goals: A Study to Increase Self-Efficacy in First-Year College Students
The current study aims to prevent the developmental of mental health symptoms in first-year college students through providing a workshop aimed at preparing students for the academic, social, and personal challenges associated with typical college experiences. Specifically, the study hypothesizes that first-year student students who participate in a workshop on college readiness will report fewer symptoms of depression and anxiety, higher levels of self-esteem, and better academic performance compared to a similar group of students who do not receive the intervention (the control group). Students in the intervention group will participate in a one-time, two-hour workshop that discusses expectations about college, setting goals that are aligned with one's values, predicting barriers to achieving these goals, and how to overcome these obstacles. The workshop will provide students with external resources (both on and off campus) for obtaining additional support to address barriers that arise during their college experiences. Students will complete questionnaires about symptoms of depression, anxiety, and their ability to cope with stress before the workshop, after the workshop, and at the end of their first semester. At the end of the Fall 2021 semester, students will be asked to share information about their Grade Point Average (GPA) and academic status. The investigators predict that at the end of the semester, those students who participated in the workshop will report lower levels of depression, anxiety and stress, higher levels of self-esteem, and a higher GPA compared to students who did not receive the intervention. Students who participated in the workshop will also be more likely to continue (enrolled in the Spring 2022 semester) compared to controls.
- Conditions
- Depression, Anxiety
- Being tested
- Scoring Your College Goals Workshop, Placebo
- Keywords
- Depression, Anxiety, College Mental Health, Mental Health Prevention
- Medical subject headings
- Depression, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Scoring Your College Goals WorkshopBehavioural
A two-hour virtual college readiness workshop.
PlaceboOther
Placebo Treatment-As-Usual Group which does not receive the workshop intervention
| Study group | Role | What they receive |
|---|---|---|
| College Workshop Arm | Experimental | Intervention Receives: Behavioral: Scoring Your College Goals Workshop |
| Placebo | Placebo comparator | Placebo Receives: Other: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Self-Reported Depression Symptoms on the DASS-21
Change in Depression Symptoms as measured by self-report on the Depression sub scale of the Depression, Anxiety and Stress Scale (DASS-21). Each sub scale of the DASS-21 has a range of 0-(lowest) to 42 (highest) with higher scores indicating worsening levels of psychopathology.
Measured: Three Months
Change in Anxiety Symptoms as measured by the DASS-21
Participants in the intervention arm but not the placebo group will demonstrate change in Depression Symptoms as measured by participant self-report on the Anxiety subscale of the Depression, Anxiety and Stress Scale (DASS-21).
Measured: Three Months
Secondary outcomes (2)
Change in self-efficacy as measured by the Coping Self-Efficacy Scale
Participants in the intervention group but not the control group will demonstrate significant change in self-reported self-efficacy scores as measured by the Coping Self-Efficacy Scale (CSE). Each sub scale of the CSE has a range of scores from 0 (lowest) to 60 (highest) with a higher score representing better (improved) coping self-efficacy.
Measured: Three Months
Change in Coping abilities as measured by the Brief COPE
Participants in the intervention group but not the control group will demonstrate significant change in their ability to cope with stress as measured by self-reported total scores on the Brief COPE. The fourteen sub scales of the Brief COPE each have a range of 0 (lowest) to 8 (highest) with higher scores indicating higher levels of coping ability.
Measured: Three Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2021
- Study start27 Aug 2021
- Primary completion1 Mar 2022 (estimated)
- Study completion30 Apr 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DepressionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 126 participants (actual)
Sponsor and investigators
- Lead sponsor
- The Zucker Hillside Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- College of Staten Island, the City University of New York
- Responsible party
- Principal investigator, Timothy Michaels, PhD, The Zucker Hillside Hospital
- Investigators
- Timothy I Michaels, PhD, Principal investigator, The Zucker Hillside Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05047081
- Sponsor's protocol ID
- 21-0500
- Status last verified
- Feb 2022
- First submitted
- 31 Aug 2021
- Last updated
- 25 Feb 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Feb 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Scoring Your College Goals: A Study to Increase Self-Efficacy in First-Year College Students
- ClinicalTrials.gov ID
- NCT05047081
- Acronym / sponsor ID
- 21-0500
- Conditions
- Depression, Anxiety
- Keywords
- Depression, Anxiety, College Mental Health, Mental Health Prevention
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 126 participants (actual)
- Lead sponsor
- The Zucker Hillside HospitalUniversity, hospital or other
- Collaborators
- College of Staten Island, the City University of New York
- Study start
- 27 Aug 2021 (actual)
- Primary completion
- 1 Mar 2022 (estimated)
- Study completion
- 30 Apr 2022 (estimated)
- First posted
- 16 Sep 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The current study aims to prevent the developmental of mental health symptoms in first-year college students through providing a workshop aimed at preparing students for the academic, social, and personal challenges associated with typical college experiences. Specifically, the study hypothesizes that first-year student students who participate in a workshop on college readiness will report fewer symptoms of depression and anxiety, higher levels of self-esteem, and better academic performance compared to a similar group of students who do not receive the intervention (the control group). Students in the intervention group will participate in a one-time, two-hour workshop that discusses expectations about college, setting goals that are aligned with one's values, predicting barriers to achieving these goals, and how to overcome these obstacles. The workshop will provide students with external resources (both on and off campus) for obtaining additional support to address barriers that arise during their college experiences. Students will complete questionnaires about symptoms of depression, anxiety, and their ability to cope with stress before the workshop, after the workshop, and at the end of their first semester. At the end of the Fall 2021 semester, students will be asked to share information about their Grade Point Average (GPA) and academic status. The investigators predict that at the end of the semester, those students who participated in the workshop will report lower levels of depression, anxiety and stress, higher levels of self-esteem, and a higher GPA compared to students who did not receive the intervention. Students who participated in the workshop will also be more likely to continue (enrolled in the Spring 2022 semester) compared to controls.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| College Workshop Arm | Experimental | Behavioral: Scoring Your College Goals WorkshopIntervention |
| Placebo | Placebo comparator | Other: PlaceboPlacebo |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- First-year, first semester freshman enrolled in Psychology 100 courses at CUNY College of Staten Island.
Key exclusion criteria (2 listed)
- Under 18 years old
- Violation of inclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Scoring Your College Goals WorkshopA two-hour virtual college readiness workshop. | Behavioural | College Workshop Arm |
| PlaceboPlacebo Treatment-As-Usual Group which does not receive the workshop intervention | Other | Placebo |
Primary outcome
Change in Self-Reported Depression Symptoms on the DASS-21
Time frame: Three Months
Change in Depression Symptoms as measured by self-report on the Depression sub scale of the Depression, Anxiety and Stress Scale (DASS-21). Each sub scale of the DASS-21 has a range of 0-(lowest) to 42 (highest) with higher scores indicating worsening levels of psychopathology.
Change in Anxiety Symptoms as measured by the DASS-21
Time frame: Three Months
Participants in the intervention arm but not the placebo group will demonstrate change in Depression Symptoms as measured by participant self-report on the Anxiety subscale of the Depression, Anxiety and Stress Scale (DASS-21).
2 secondary outcomes
Change in self-efficacy as measured by the Coping Self-Efficacy Scale
Time frame: Three Months
Change in Coping abilities as measured by the Brief COPE
Time frame: Three Months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Feb 2022.
- Individual participant dataSharing planned: No
Related trials for Depression
RecruitingPhase 1
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
Depression, Major Depressive Disorder
Recruiting
To Improve Depressive Symptoms Using a Web-App
Depression
Active, not recruiting
Supporting Health in Veterans With Heart Failure
Heart Failure
Recruiting
Cancer Pain Management Using a Web-based Intervention
Cancer of Breast, Depressive Symptoms
Recruiting
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
Suicide, Bereavement
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Timothy I Michaels, PhD principal investigator
The Zucker Hillside Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Scoring Your College Goals Workshop in people with Depression and Anxiety, run by The Zucker Hillside Hospital at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 25 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Self-Reported Depression Symptoms on the DASS-21 (time frame: Three Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2022; AzTrials last refreshed its copy on 2 Nov 2026.